Key result
The miniECG detected occlusive myocardial infarction with a sensitivity of 65% and specificity of 92%, compared with 83% and 90% for the clinical 12-lead ECG.
Why the study?
Most portable ECG devices are single-lead and only intended for rhythm disorders, leaving a need to evaluate whether a novel portable multi-lead device can detect occlusive myocardial infarction in patients with chest pain.
Does the miniECG device accurately detect occlusive myocardial infarction in patients presenting with acute chest pain compared to a standard 12-lead ECG?
Cross-Sectional (n=369)
Yes
Does the miniECG device accurately detect occlusive myocardial infarction in patients presenting with acute chest pain compared to a standard 12-lead ECG?
Absolute Event Rate: 65% vs 83%
The novel miniECG device demonstrated high specificity (92%) but moderate sensitivity (65%) for detecting occlusive myocardial infarction, suggesting potential utility as a rule-in diagnostic tool.
No takes yet. Share an insight, caveat, or question.
Lower sensitivity than 12-lead ECG cautions against standalone use; leaves open prospective validation of miniECG as a rule-in tool.
Leur et al. (2024) conducted a cross-sectional in Acute chest pain (n=369). miniECG vs. 12-lead ECG was evaluated on Detection of occlusive myocardial infarction (OMI). The miniECG detected occlusive myocardial infarction with a sensitivity of 65% and specificity of 92%, compared with 83% and 90% for the clinical 12-lead ECG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: